Biphenyl

Biphenyl

SCHEMBL2172478

O=[PH]([O-])[O-].[O-2].[Zr+4].c1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ MAPT P10636 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NOTUM Q6P988 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ BCL2L1 Q07817 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ WDR5 P61964 1/20 0.37
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL9009484 0.79 ALDH1A1 (0.43) ALDH1A1CA12CA1CA2CA9
Biphenyl SCHEMBL27743176 0.77 ALDH1A1 (0.75) ALDH1A1CA12CA1CA2CA9
Benzene SCHEMBL7909473 0.77 TP53 (0.30) TSHR
Phosphonic Acid SCHEMBL31683802 0.77 ALDH1A1 (0.37) ALDH1A1CA12CA1CA2CA9
Biphenyl SCHEMBL9009477 0.75 ALDH1A1 (0.60) ALDH1A1CA1CA2MAPTLMNA
Biphenyl SCHEMBL987489 0.75 ALDH1A1 (0.60) ALDH1A1CA1CA2MAPTLMNA
Biphenyl SCHEMBL2336844 0.75 ALDH1A1 (0.60) ALDH1A1CA12CA1CA2CA9
Biphenyl SCHEMBL11137586 0.75 ALDH1A1 (0.60) ALDH1A1CA1CA2MAPTLMNA
Biphenyl SCHEMBL27643334 0.73 ALDH1A1 (0.82) ALDH1A1CA1CA2MAPTLMNA
Biphenyl SCHEMBL4002609 0.73 ALDH1A1 (1.00) ALDH1A1CA1CA2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973109-B2 Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2011-07-05 — — US disclosed
US-20090093607-A1 Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093607-A1 Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution WEE1, WEE2, PPIP5K2 ALDH1A1 3622/4885CA12 3110/4885CA1 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback